| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 03/15/2001 | CA2383086A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/14/2001 | EP1082362A1 Supported group 8-10 transition metal olefin polymerization catalysts |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082121A1 Hiv integrase inhibitors |
| 03/14/2001 | EP1082110A1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/13/2001 | US6200972 Heterocyclic esters and amides |
| 03/13/2001 | US6200925 As polymerization catalyst |
| 03/08/2001 | WO2001016121A1 Heterocyclic compounds and methods of use thereof |
| 03/08/2001 | WO1999063930A8 Novel angiotensin receptor modulators and their uses |
| 03/07/2001 | EP1081137A1 Selective inhibitors of aggrecanase in osteoarthritis treatment |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1080068A1 Modulators of protein tyrosine phosphatases |
| 03/07/2001 | EP1079835A1 Pyrazinone thrombin inhibitors |
| 03/07/2001 | EP0641325B1 Retroviral protease inhibitors |
| 03/07/2001 | CN1286684A Carboxamide derivs. of pyrrolidine, piperidine and hexahydroazepine for treatment of thrombosis disorders |
| 03/07/2001 | CN1286254A Aromatic amino ether as analgesics |
| 03/07/2001 | CN1062865C Process for production of amidinobenzofuran and amidinobenzothiophen derivs. and salt thereof |
| 03/06/2001 | US6197773 N-acyl and N-aroyl aralkyl amides as serotonergic agents |
| 03/01/2001 | WO2001014371A1 N-heterocyclic derivatives as nos inhibitors |
| 03/01/2001 | WO2001014355A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 03/01/2001 | WO2001014339A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/01/2001 | WO2000071516B1 INHIBITORS OF FACTOR Xa |
| 03/01/2001 | CA2382311A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 03/01/2001 | CA2376275A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/27/2001 | US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 02/27/2001 | US6194416 Central nervous system disorders; alzheimer's disease |
| 02/27/2001 | US6194412 Mixtures derived from grains of Eugenia Jambolana Lamarck preparation and use of said mixtures and some of their constituents as medicaments |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/22/2001 | WO2001012614A1 N-oxyl radicals |
| 02/22/2001 | WO2001012600A1 INHIBITORS OF FACTOR Xa |
| 02/22/2001 | WO2001012591A1 Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 02/22/2001 | WO2001012233A2 Sustained release formulation of a peptide |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | DE19939745A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives as microsomal triglyceride transfer protein inhibitors, useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/22/2001 | DE19939516A1 New 1-carboxyalkyl-4-(hetero)aryl-piperazine derivatives, as microsomal triglyceride transfer protein inhibitors useful for reducing plasma atherogenic lipoprotein levels, e.g. in treatment of hyperlipidemia |
| 02/22/2001 | DE19939031A1 N-Oxyl-Radikale N-oxyl radicals |
| 02/21/2001 | CN1284953A Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 02/20/2001 | US6191182 Subjecting p-halophenyl alkyl ketone to aminolysis with cyclic secondary amine to form cyclic amine-substituted phenyl alkyl ketone; halogination and reacting with amine compound; stevens rearrangement under basic condition |
| 02/20/2001 | US6191134 Stroke therapy, antiischemic agents, brain disorders |
| 02/20/2001 | US6191132 Use of quisqualate receptor antagonists |
| 02/20/2001 | US6190852 Coupler provides a desirably narrow spectrographic absorption curve. |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010834A2 Antibacterial agents |
| 02/15/2001 | WO2001010799A1 Methods for preparing n-[(aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds |
| 02/15/2001 | CA2381008A1 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/14/2001 | EP1075469A1 Piperazine derivatives and process for the preparation thereof |
| 02/14/2001 | EP1075468A1 Method for producing high melting point crystals of phenoxypropionic acid derivative |
| 02/13/2001 | US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent |
| 02/13/2001 | US6187943 Catalyzing the reaction in the presence of a metal oxide catalyst containing vanadium and/or molybdenum in a fluidized bed |
| 02/13/2001 | US6187812 For controlling animal pests or harmful fungi; (e,e,e)-2-methoxyimino-2-(2'-(1?-methyl, 1?-(1?'-ethoxyiminoethyl))iminooxymethyl)phenylacetic acid monomethylamide, for example |
| 02/13/2001 | US6187776 Heterocyclic compounds and their use |
| 02/08/2001 | WO2000076984A3 Novel compounds, their use and preparation |
| 02/07/2001 | EP1073644A1 Solid supported synthesis of sulfonated 2-oxopiperazines |
| 02/07/2001 | EP1073638A1 Heterocyclically substituted amides, their production and their use |
| 02/07/2001 | EP1073626A1 Azine used as fungicides |
| 02/07/2001 | EP0538422B1 New use of diphenylbutylpiperazinecarboxamides in the treatment of substance disorders |
| 02/07/2001 | CN1283195A 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype ligands |
| 02/07/2001 | CN1283180A Inhibition of raf kinase using symmerical and unsymmerical substituted diphenyl ureas |
| 02/06/2001 | US6184224 Drug resistance and side effect reduction |
| 02/06/2001 | CA2027349C Light polarizing materials and suspensions thereof |
| 02/01/2001 | WO2001007436A2 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | WO2001007419A1 Novel thiazine or pyrazine derivatives |
| 02/01/2001 | WO2001007411A1 Biarylurea derivatives |
| 02/01/2001 | CA2382755A1 Substituted oxoazaheterocyclyl compounds |
| 02/01/2001 | CA2380389A1 Biarylurea derivatives |
| 02/01/2001 | CA2380218A1 Novel thiazine or pyrazine derivatives |
| 01/31/2001 | EP1071669A1 Bicyclic compounds having an anti-thrombitic effect |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/30/2001 | US6180646 Retroviral protease inhibitors |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | US6180623 Used as analgesics and anti-pruritic agents |
| 01/30/2001 | US6180619 Prenyl transferase inhibitors |
| 01/25/2001 | WO2001005773A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
| 01/25/2001 | WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/25/2001 | WO2001005748A1 Oligomeric amino acid derivatives useful as nitric oxide synthase inhibitors |
| 01/25/2001 | WO2001005398A1 Phosphate transport inhibitors |
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005354A2 Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/25/2001 | WO2000058293A3 Glucokinase activators |
| 01/25/2001 | CA2379657A1 Phosphate transport inhibitors |
| 01/25/2001 | CA2378181A1 Conjugates of sodium channel blockers and methods of using the same |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/24/2001 | EP1070084A1 PIPERAZINES AS INHIBITORS OF FRUCTOSE-1,6-BISPHOSPHATASE (FBPase) |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1070054A1 Amine compounds, their production and their use as somatostatin receptor antagonists or agonists |
| 01/24/2001 | CN1281449A Crystalline antifungal polymorph |
| 01/24/2001 | CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 01/24/2001 | CN1281335A Treatment of schizophrenia with ampakines and neuroleptics |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | CA2128202C Alkyl derivatives of trazodone with cns activity |
| 01/18/2001 | WO2001004097A2 Cyclic delocalized cations connected by spacer groups |
| 01/18/2001 | WO2000071516A3 INHIBITORS OF FACTOR Xa |
| 01/17/2001 | EP1068200A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/17/2001 | EP1068190A1 Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |